L
Lars Rombo
Researcher at Uppsala University
Publications - 162
Citations - 5404
Lars Rombo is an academic researcher from Uppsala University. The author has contributed to research in topics: Malaria & Chloroquine. The author has an hindex of 35, co-authored 156 publications receiving 4857 citations. Previous affiliations of Lars Rombo include University of Oxford & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Anthony L. Cunningham,Himal Lal,Martina Kovac,Roman Chlibek,Shinn-Jang Hwang,Javier Díez-Domingo,Olivier Godeaux,Myron J. Levin,Janet E. McElhaney,Joan Puig-Barberà,C. Vanden Abeele,Timo Vesikari,Daisuke Watanabe,Toufik Zahaf,Anitta Ahonen,Eugene Athan,J. F. Barba-Gomez,Laura Campora,F. de Looze,H. J. Downey,Wayne Ghesquiere,Iris Gorfinkel,Tiina Korhonen,Edward M. F. Leung,Shelly A. McNeil,Lidia Oostvogels,Lars Rombo,Jan Smetana,Lily Yin Weckx,Wilfred W Yeo,Thomas C. Heineman +30 more
TL;DR: HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older.
Journal ArticleDOI
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
Elizabeth A. Ashley,Francesca T. Aweeka,Karen I. Barnes,Quique Bassat,Steffen Borrmann,Steffen Borrmann,Prabin Dahal,Prabin Dahal,Tme Davis,Philippe Deloron,Mey Bouth Denis,Abdoulaye Djimde,Jean-François Faucher,Blaise Genton,Blaise Genton,Philippe J Guerin,Kamal Hamed,Eva Maria Hodel,Eva Maria Hodel,Liusheng Huang,Jullien,Harin Karunajeewa,Harin Karunajeewa,Kiechel,Poul-Erik Kofoed,Gilbert Lefèvre,Niklas Lindegardh,Kevin Marsh,Kevin Marsh,Andreas Mårtensson,Mayfong Mayxay,Mayfong Mayxay,Rose McGready,C Moreira,Paul N. Newton,Billy Ngasala,François Nosten,Christian Nsanzabana,Christian Nsanzabana,Sunil Parikh,Ric N. Price,Pascal Ringwald,Lars Rombo,Lars Rombo,Birgit Schramm,Carol Hopkins Sibley,Kasia Stepniewska,Johan Ursing,Michèle van Vugt,Michèle van Vugt,Nicholas J. White,Lesley Workman +51 more
TL;DR: Higher, more frequent, or prolonged dosage regimens should now be evaluated in very young children, particularly if malnourished, and in patients with hyperparasitemia, as well as patients in very low transmission intensity areas with emerging parasite resistance.
Journal ArticleDOI
The true burden and risk of cholera: implications for prevention and control
TL;DR: This work has identified, through extensive literature searches, additional outbreaks of cholera to those reported to WHO, many of which originated from the Indian subcontinent and southeast Asia.
Journal ArticleDOI
Polymorphisms in Plasmodium falciparum chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine
Meera Venkatesan,Nahla B Gadalla,Kasia Stepniewska,Prabin Dahal,Christian Nsanzabana,Clarissa Moriera,Ric N. Price,Andreas Mårtensson,Philip J. Rosenthal,Grant Dorsey,Colin J. Sutherland,Philippe J Guerin,Timothy M. E. Davis,Didier Menard,Ishag Adam,George O. Ademowo,Cesar Arze,Frederick N. Baliraine,Nicole Berens-Riha,Anders Björkman,Steffen Borrmann,Francesco Checchi,Meghna Desai,Mehul Dhorda,Abdoulaye Djimde,Badria B. El-Sayed,Teferi Eshetu,Frederick Eyase,Catherine O. Falade,Jean-François Faucher,Gabrielle Fröberg,Anastasia Grivoyannis,Sally Hamour,Sandrine Houzé,Jacob D. Johnson,Erasmus Kamugisha,Simon Kariuki,Jean-René Kiechel,Fred Kironde,Fred Kironde,Poul-Erik Kofoed,Jacques Lebras,Maja Malmberg,Maja Malmberg,Leah Mwai,Leah Mwai,Billy Ngasala,François Nosten,Samuel L. Nsobya,Alexis Nzila,Alexis Nzila,Mary C. Oguike,Sabina Dahlström Otienoburu,Bernhards Ogutu,Jean-Bosco Ouédraogo,Patrice Piola,Patrice Piola,Lars Rombo,Birgit Schramm,A. Fabrice Some,Julie Thwing,Johan Ursing,Rina P. M. Wong,Ahmed Zeynudin,Issaka Zongo,Christopher V. Plowe,Carol Hopkins Sibley,Carol Hopkins Sibley +67 more
TL;DR: Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine.
Journal ArticleDOI
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
Alemnew F Dagnew,Osman Ilhan,Won Sik Lee,Dariusz Woszczyk,Jae Yong Kwak,Stella Bowcock,Sang Kyun Sohn,Gabriela Rodriguez Macías,Tzeon Jye Chiou,Dimas Quiel,Mickael Aoun,Maria Belen Navarro Matilla,Javier de la Serna,Sam Milliken,John Murphy,Shelly A. McNeil,Bruno Salaun,Emmanuel Di Paolo,Laura Campora,Marta López-Fauqued,Mohamed El Idrissi,Anne Schuind,Thomas C. Heineman,Peter Van den Steen,Lidia Oostvogels,Kadir Acar,Boris Afanasyev,Aránzazu Alonso Alonso,Veli-Jukka Anttila,Pere Barba Suñol,Norbert Blesing,Terrance Comeau,Teresa del Campo,Patricia Disperati,Richard Eek,Hyeon Seok Eom,Gianluca Gaidano,Sebastian Grosicki,Thierry Guillaume,Wojciech Homenda,William Hwang,Nikolay Ilyin,Anna Johnston,Seok Jin Kim,Ching Yuan Kuo,Aleksey Kuvshinov,Dong-Gun Lee,Jae Hoon Lee,Je Jung Lee,Stephane Lepretre,Albert Kwok Wai Lie,Alessandro Lucchesi,Ahmed Masood,Naheed Mir,Anna Carolina Miranda Castillo,Kathleen M. Mullane,Alexandr Myasnikov,Raquel Oña Navarrete,Karlis Pauksens,Andrew Peniket,Jaime Pérez de Oteyza,David Pohlreich,Humphrey Pullon,Philippe Quittet,Philippe Rodon,Lars Rombo,Olga Samoylova,Johan Sanmartin Berglund,Ariah Schattner,Dominik Selleslag,Marjatta Sinisalo,Faisal Sultan,Koen Theunissen,Paul Turner,Po Nan Wang,Lucrecia Yáñez San Segundo,Jo Anne H. Young,Pierre Zachee,Francesco Zaja +78 more
TL;DR: The immunocompromised adult population with haematological malignancies is at high risk for herpes zoster and the adjuvanted recombinant zoster vaccine, which is currently licensed in certain countries for adults aged 50 years and older, is likely to benefit this population.